Management of Postural Orthostatic Tachycardia Syndrome (POTS)

Diagnostic Confirmation

The European Heart Journal recommends confirming POTS diagnosis with proper orthostatic vital sign measurement, including a heart rate increase ≥30 bpm (or ≥40 bpm in ages 12-19 years) within 10 minutes of standing, without orthostatic hypotension 2, 3
The American College of Cardiology suggests measuring blood pressure and heart rate supine after 5 minutes rest, then at 1, 3, 5, and 10 minutes of standing, to confirm POTS diagnosis 1
Documenting associated symptoms such as light-headedness, palpitations, tremor, weakness, blurred vision, and fatigue is crucial for diagnosis, as recommended by the European Heart Journal 2, 3

The American College of Cardiology recommends beginning with non-pharmacological interventions as first-line therapy for all POTS patients, including aggressive salt and fluid loading (5-10 g sodium and 3 liters of fluid daily) 1
The American College of Cardiology suggests using waist-high compression stockings to ensure sufficient support of central blood volume 1
Elevating the head of bed with 4-6 inch blocks during sleep is recommended by the American College of Cardiology to help manage POTS symptoms 1
A structured exercise reconditioning program is critical and has been shown to support long-term cardiovascular health, as recommended by the American College of Cardiology 1

The American College of Cardiology recommends using low-dose beta-blockers as first-line agents for palpitations and tachycardia, with propranolol being particularly useful in hyperadrenergic POTS with coexisting anxiety or migraine 1
The American College of Cardiology suggests using ivabradine as an alternative rate-control agent, especially in patients with severe fatigue exacerbated by beta-blockers 1, 6
Fludrocortisone may be used to increase blood volume, with a dose of up to 0.2 mg taken at night, as recommended by the American College of Cardiology 1
Midodrine may be used to enhance vascular tone, particularly in neuropathic POTS, with a dose of 2.5-10 mg, and the first dose taken in the morning before getting out of bed, as recommended by the American College of Cardiology 1

POTS predominantly affects young women and is frequently associated with recent infections or trauma, chronic fatigue syndrome, joint hypermobility syndrome, and deconditioning following illness or injury, as noted by the European Heart Journal 2, 3
The American College of Cardiology recognizes three major pathophysiologic phenotypes that guide treatment selection: hyperadrenergic POTS, neuropathic POTS, and hypovolemic POTS 1

The American College of Cardiology recommends confirming diagnosis with proper orthostatic vital signs, initiating non-pharmacological interventions in all patients, and adding pharmacotherapy based on predominant symptoms 1
The European Heart Journal suggests titrating medications gradually and weaning as conditioning improves 2, 3

The American College of Cardiology warns against using beta-blockers or rate-lowering agents if orthostatic hypotension is present, as this may cause severe worsening 6
The European Heart Journal advises against dismissing symptoms as "just anxiety" in young patients, particularly young women with recent infections 2, 4